Executive Director, Oncology DD & Commercialization Communications

Role: Executive Director of Oncology Drug Development & Commercialization Communications at Bristol Myers Squibb, leading global strategic communications for the oncology portfolio, including marketed brands, pipeline assets, and new indications across solid tumors, hematologic malignancies, and cell therapies. Responsibilities: develop integrated internal and external messaging, manage thought leadership initiatives, oversee milestone and pipeline communications, and advise senior leaders; foster cross-functional collaboration and global stakeholder engagement; lead issues management, reputational risk mitigation, and digital/social media strategies; direct team development, budget, and measurement practices. Requirements: 15+ years in pharmaceutical or healthcare communications, with expertise in brand/corporate strategy, issues management, and multi-channel campaigns; experience in oncology, hematology, or cell therapy preferred; strong leadership, stakeholder influence, and regulatory policy knowledge; bachelor’s degree (master’s preferred). High-Value: oncology (solid tumors, hematologic malignancies, cell therapy), late-stage pipeline, global scope, influence on corporate reputation, internal/external stakeholder engagement, digital/social media expertise, based in Princeton, NJ with some Lawrenceville, NJ. Work setup: hybrid environment.